Quoin Pharmaceuticals Files 8-K on Financials
Ticker: QNRX · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1671502
| Field | Detail |
|---|---|
| Company | Quoin Pharmaceuticals, Ltd. (QNRX) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations-update
TL;DR
Quoin Pharma (QN) filed an 8-K. Financials and Ops update. Check it out.
AI Summary
Quoin Pharmaceuticals, Ltd. filed an 8-K on March 13, 2025, reporting on its Results of Operations and Financial Condition. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd., is incorporated in Israel and has its principal executive offices in Ashburn, VA. The filing does not contain specific financial figures or operational details beyond its classification as a pharmaceutical preparations company.
Why It Matters
This 8-K filing indicates Quoin Pharmaceuticals is providing an update on its financial condition and operations, which is crucial for investors to assess the company's current status.
Risk Assessment
Risk Level: medium — The filing is a standard 8-K for financial reporting, but lacks specific details, making it difficult to assess immediate risks without further information.
Key Players & Entities
- Quoin Pharmaceuticals, Ltd. (company) — Filer of the 8-K
- Cellect Biotechnology Ltd. (company) — Former name of Quoin Pharmaceuticals
- Cellect Biomed Ltd. (company) — Former name of Quoin Pharmaceuticals
- March 13, 2025 (date) — Date of report
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text of the 8-K filing does not contain specific financial figures or operational details beyond stating the report is concerning 'Results of Operations and Financial Condition'.
When was Quoin Pharmaceuticals, Ltd. previously known by other names?
Quoin Pharmaceuticals, Ltd. was formerly known as Cellect Biotechnology Ltd. (name change date 20160721) and Cellect Biomed Ltd. (name change date 20160406).
Where are Quoin Pharmaceuticals, Ltd.'s principal executive offices located?
Quoin Pharmaceuticals, Ltd.'s principal executive offices are located at 42127 Pleasant Forest Court, Ashburn, VA 20148-7349.
What is the Standard Industrial Classification (SIC) code for Quoin Pharmaceuticals, Ltd.?
The Standard Industrial Classification (SIC) code for Quoin Pharmaceuticals, Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date of this 8-K report?
This 8-K report was filed on March 13, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding Quoin Pharmaceuticals, Ltd. (QNRX).